Randomized Controlled Trial
The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers.
Addiction. 2011 Aug 1;106(8):1460-73.
Randomized Controlled Trial
The multi-site prescription opioid addiction treatment study: 18-month outcomes.
J Subst Abuse Treat. 2015 Jan 1; 48 (1): 62-9.
Randomized Controlled Trial
Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population.
J Clin Psychiatry. 2015 Feb 1; 76 (2): 189-94.